Combined metformin-salicylate treatment provides improved anti-tumor activity and enhanced radiotherapy response in prostate cancer; drug synergy at clinically relevant doses-Reference-Cited by-同舟云学术

Combined metformin-salicylate treatment provides improved anti-tumor activity and enhanced radiotherapy response in prostate cancer; drug synergy at clinically relevant doses

Published:2021-11 Issue:11 Volume:14 Page:101209
ISSN:1936-5233
Container-title:Translational Oncology
language:en
Short-container-title:Translational Oncology

Author:

Tsakiridis Evangelia E.,Broadfield Lindsay,Marcinko Katarina,Biziotis Olga-Demetra,Ali Amr,Mekhaeil Bassem,Ahmadi Elham,Singh Kanwaldeep,Mesci Aruz,Zacharidis Panayiotis G.,Anagnostopoulos Alexander E.,Berg Tobias,Muti Paola,Steinberg Gregory R.,Tsakiridis Theodoros

Publisher

Elsevier BV

Subject

Cancer Research,Oncology

Reference43 articles.

1. Projected estimates of cancer in Canada in 2020;Brenner;CMAJ,2020

2. Jemal a. cancer statistics, 2020;Siegel;CA Cancer J. Clin.,2020

3. Improved biochemical relapse-free survival with increased external radiation doses in patients with localized prostate cancer: the combined experience of nine institutions in patients treated in 1994 and 1995;Kupelian;Int. J. Radiat. Oncol. Biol. Phys.,2005

4. Randomized trial comparing conventional-dose with high-dose conformal radiation therapy in early-stage adenocarcinoma of the prostate: long-term results from proton radiation oncology group/american college of radiology 95-09;Zietman;J. Clin. Oncol.,2010

5. An inhibitor of oxidative phosphorylation exploits cancer vulnerability;Molina;Nat. Med.,2018

Cited by 11 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Metformin as anticancer agent and adjuvant in cancer combination therapy: Current progress and future prospect;Translational Oncology;2024-06

2. Additive Cytotoxic and Colony-Formation Inhibitory Effects of Aspirin and Metformin on PI3KCA-Mutant Colorectal Cancer Cells;International Journal of Molecular Sciences;2024-05-15

3. AMPK Alchemy: Therapeutic Potentials in Allergy, Aging, and Cancer;Biomolecules & Therapeutics;2024-02-13

4. Diabetes and the prostate;Journal of the Pakistan Medical Association;2023-11-28

5. The SGLT2 inhibitor canagliflozin suppresses growth and enhances prostate cancer response to radiotherapy;Communications Biology;2023-09-08